Search

everythinglearnresearchcommunity

for

Search:↓

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Women with excessive hair growth often have hormonal issues and need medical advice and treatment.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Women with PCOS have more severe liver disease.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Overweight women with PCOS are more likely to have excess male hormones.

Ovarian drilling surgery is not clearly better than medical treatments for PCOS symptoms.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.